Skip to main content

Animations

MJFF Publications

3001 - 3010 of 9145 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ner.13504
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10286-022-00853-6
    Citation Count: 19
  • Summary Details
    OPEN
    Title: SHIP164 is a chorein motif lipid transfer protein that controls endosome–Golgi membrane traffic
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202111018
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells
    Journal Name: FEBS Open Bio
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/2211-5463.13398
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103022
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)
    Journal Name: BMJ Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab431
    Citation Count: 190
  • Summary Details
    OPEN
    Title: Automatic Speech Recognition in Noise for Parkinson's Disease: A Pilot Study
    Journal Name: Frontiers in Artificial Intelligence
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/frai.2021.809321
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcab293
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012952
    Citation Count: 80
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.